Related Experiment Video
Updated: Feb 15, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Candesartan, angiotensin II type 1 receptor blocker is able to relieve age-related cognitive impairment
Emil Trofimiuk1, Przemysław Wielgat1, Jan J Braszko1
1Department of Clinical Pharmacology, Medical University of Bialystok, Białystok, Poland.
Insights
Candesartan, an antihypertensive drug, may improve age-related memory decline in rats by enhancing recognition memory. However, it can also worsen memory recall in some instances, suggesting complex effects on cognitive function.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Candesartan is a widely used antihypertensive medication from the angiotensin II receptor blocker (ARB) class.
- Its efficacy in managing hypertension is well-established.
- This study investigated candesartan's potential to mitigate age-related memory impairments.
Purpose of the Study:
- To evaluate the effects of candesartan on age-associated memory decline in a rat model.
- To assess candesartan's impact on long-term memory, recognition memory, locomotor activity, and anxiety.
Main Methods:
- Young and aged rats received candesartan (0.1 mg/kg) daily for 21 days.
- Behavioral tests included Passive Avoidance (PA) for long-term memory and Object Recognition (OR) for recognition memory.
- Locomotor activity (Open Field - OF) and anxiety (Elevated Plus Maze - EPM) were also assessed.
Main Results:
- Aged rats exhibited impaired passive avoidance memory retrieval, indicating increased forgetting.
- Candesartan treatment significantly reversed this forgetting in aged rats.
- Recognition memory in aged rats was significantly enhanced by candesartan, surpassing even young rats' performance.
Conclusions:
- Candesartan demonstrates potential in reversing certain types of age-induced memory deficits in rats.
- The drug's effects on memory are complex, with potential for both improvement and deterioration depending on the cognitive domain.
- Sartans may represent a therapeutic option for hypertensive patients with or at risk of cognitive impairment.
Background:
Candesartan is one of the standard antihypertensive drug belonging to AT1R angiotensin receptor blockers (ARBs) group. Beneficial effects of this drug in the treatment of hypertension are well recognized. In this study we tested a hypothesis that candesartan could alleviate age-related memory decline.
Methods:
Aged and young rats have been treated with candesartan (0.1mg kg-1) for 21days and then underwent a battery of behavioral tests: for assessment of long-term memory (Passive avoidance test - PA), recognition memory (Object recognition test - OR), locomotor functions (Open field - OF) and anxiety behavior (Elevated plus maze - EPM).
Results:
Aged rats (2-years-old) displayed clear declining tendency in the retrieval of passive avoidance behavior showing thus increased forgetting. Prolonged administration of candesartan significantly (p<0.01) reversed this phenomenon causing recall measured as the avoidance latency, and surprisingly also showed the tendency to recall deterioration observed in the young rats. More optimistic results were achieved in the OR, where candesartan significantly improved recognition memory (p<0.001) of aged rats who performed even better than the young ones (p<0.05).
Conclusions:
It appears that candesartan potently abolishes some kinds of aging-induced memory impairments and cognitive declines in aged rats, but in some circumstances it may even could increase the damage of memory. It seems that the use of sartans in the treatment of hypertension for patients with associated cognitive impairment, or for people in risk groups for such disorders can be an interesting alternative.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Antihypertensive Drugs: Action of β1 Blockers
Piaget's Stage 1 of Cognitive Development
Exploration...
Types of Receptors: Cell Surface Receptors
Antihypertensive Drugs: Types of β-Blockers